Biocryst Pharmaceuticals (BCRX) Change in Inventory (2010 - 2026)

Biocryst Pharmaceuticals' Change in Inventory history runs 13 years deep, the most recent figure standing at $4.8 million for Q1 2026.

• Quarterly Change in Inventory rose 457.13% year-over-year to $4.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.6 million (up 47.25% YoY) and the FY2025 annual result came in at $1.6 million, down 60.64% from the prior year.
• Change in Inventory was $4.8 million for Q1 2026 at Biocryst Pharmaceuticals, up from $515000.0 in the prior quarter.
• Across five years, Change in Inventory topped out at $7.2 million in Q2 2022 and bottomed at -$1.4 million in Q2 2025.
• A 5-year average of $1.4 million and a median of $1.2 million in 2022 frame the typical range for Change in Inventory.
• Annual changes were most pronounced in 2023 — Change in Inventory plunged 178.19% — and 2024, when it soared 1031.3%.
• Biocryst Pharmaceuticals' Change in Inventory stood at $1.2 million in 2022, then sank by 178.19% to -$907000.0 in 2023, then jumped by 338.48% to $2.2 million in 2024, then sank by 76.19% to $515000.0 in 2025, then jumped by 841.17% to $4.8 million in 2026.
• Business Quant data shows BCRX's Change in Inventory at $4.8 million in Q1 2026, $515000.0 in Q4 2025, and $1.7 million in Q3 2025.